NUVEEN CA QLTY MUNI INC (NAC)

US67066Y1055

11.12  -0.04 (-0.36%)

After market: 11.0807 -0.04 (-0.35%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NAC. NAC was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of NAC have multiple concerns. NAC does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

NAC had negative earnings in the past year.
In the past year NAC had a positive cash flow from operations.
In multiple years NAC reported negative net income over the last 5 years.
NAC had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -1.14%
ROE -1.95%
ROIC 0.34%
ROA(3y)-3.61%
ROA(5y)0.06%
ROE(3y)-6.03%
ROE(5y)-0.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 16.44%
PM (TTM) N/A
GM 17.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, NAC has about the same amount of shares outstanding.
NAC has less shares outstanding than it did 5 years ago.
NAC has a worse debt/assets ratio than last year.

2.2 Solvency

NAC has an Altman-Z score of 0.74. This is a bad value and indicates that NAC is not financially healthy and even has some risk of bankruptcy.
NAC has a debt to FCF ratio of 12.37. This is a negative value and a sign of low solvency as NAC would need 12.37 years to pay back of all of its debts.
A Debt/Equity ratio of 0.70 indicates that NAC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.37
Altman-Z 0.74
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

NAC has a Current Ratio of 2.20. This indicates that NAC is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.20 indicates that NAC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.73% over the past year.
Looking at the last year, NAC shows a very strong growth in Revenue. The Revenue has grown by 26.43%.
NAC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -35.14% yearly.
EPS 1Y (TTM)90.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.58%
Revenue 1Y (TTM)26.43%
Revenue growth 3Y-50.39%
Revenue growth 5Y-35.14%
Sales Q2Q%20313.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.97
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.13%, NAC is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.24, NAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.13%

5.2 History

The dividend of NAC decreases each year by -5.57%.
NAC has been paying a dividend for at least 10 years, so it has a reliable track record.
NAC has decreased its dividend recently.
Dividend Growth(5Y)-5.57%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of NAC are negative and hence is the payout ratio. NAC will probably not be able to sustain this dividend level.
DP-203.46%
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

NUVEEN CA QLTY MUNI INC

NYSE:NAC (12/20/2024, 8:26:26 PM)

After market: 11.0807 -0.04 (-0.35%)

11.12

-0.04 (-0.36%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-02 2022-05-02
Earnings (Next)N/A N/A
Inst Owners19.97%
Inst Owner Change-21.17%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.61B
Analysts45
Price TargetN/A
Short Float %0.1%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield 6.13%
Dividend Growth(5Y)-5.57%
DP-203.46%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-13 2024-12-13 (0.0735)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.26
P/FCF 15.97
P/OCF 15.97
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY6.26%
OCF(TTM)0.7
OCFY6.26%
SpS0.55
BVpS12.31
TBVpS12.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE -1.95%
ROCE 0.43%
ROIC 0.34%
ROICexc 0.34%
ROICexgc 0.34%
OM 16.44%
PM (TTM) N/A
GM 17.16%
FCFM 126.87%
ROA(3y)-3.61%
ROA(5y)0.06%
ROE(3y)-6.03%
ROE(5y)-0.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.37
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 0.74
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.43%
Revenue growth 3Y-50.39%
Revenue growth 5Y-35.14%
Sales Q2Q%20313.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.12%
FCF growth 3Y16.83%
FCF growth 5YN/A
OCF growth 1Y-12.12%
OCF growth 3Y16.83%
OCF growth 5YN/A